Skip to main content

Advertisement

Intensive Care Medicine Experimental
Intensive Care Medicine Experimental Cover Image
We’d like to understand how you use our websites in order to improve them. Register your interest.
Download PDF

New automated analysis to monitor neutrophil function point-of-care in the intensive care unit after trauma

Intensive Care Medicine Experimental volume 8, Article number: 12 (2020) Cite this article

Abstract

Background

Patients often develop infectious complications after severe trauma. No biomarkers exist that enable early identification of patients who are at risk. Neutrophils are important immune cells that combat these infections by phagocytosis and killing of pathogens. Analysis of neutrophil function used to be laborious and was therefore not applicable in routine diagnostics. Hence, we developed a quick and point-of-care method to assess a critical part of neutrophil function, neutrophil phagosomal acidification. The aim of this study was to investigate whether this method was able to analyze neutrophil functionality in severely injured patients and whether a relation with the development of infectious complications was present.

Results

Fifteen severely injured patients (median ISS of 33) were included, of whom 6 developed an infection between day 4 and day 9 after trauma. The injury severity score did not significantly differ between patients who developed an infection and patients who did not (p = 0.529). Patients who developed an infection showed increased acidification immediately after trauma (p = 0.006) and after 3 days (p = 0.026) and a decrease in the days thereafter to levels in the lower normal range. In contrast, patients who did not develop infectious complications showed high-normal acidification within the first days and increased tasset to identify patients at risk for infections after trauma and to monitor the inflammatory state of these trauma patients.

Conclusion

Neutrophil function can be measured in the ICU setting by rapid point-of-care analysis of phagosomal acidification. This analysis differed between trauma patients who developed infectious complications and trauma patients who did not. Therefore, this assay might prove a valuable asset to identify patients at risk for infections after trauma and to monitor the inflammatory state of these trauma patients.

Trial registration

Central Committee on Research Involving Human Subjects, NL43279.041.13. Registered 14 February 2014. https://www.toetsingonline.nl/to/ccmo_search.nsf/Searchform?OpenForm.

Background

Trauma patients are prone to develop infectious complications. The risk of these infections is mainly determined by the severity of the injury and the following dysregulation of the immune response [1, 2]. Over half of the severely injured patients admitted to the intensive care unit (ICU) develop an infection during hospitalization, generally after 5 days post-trauma [3]. Although infection-related mortality rates decreased over the past decades [4], severe infections such as sepsis remain a substantial cause of morbidity and mortality after trauma worldwide [5, 6].

Until now, it has not been possible to recognize patients who will develop these relatively late complications in an early phase after trauma. Generally used biomarkers such as leukocyte counts and C-reactive protein (CRP) become positive during infections and therefore have limited prognostic value [7]. Since neutrophils are the first responders to both tissue damage and invading pathogens [8, 9], multiple studies focused on neutrophils as potential biomarkers [10,11,12,13,14,15,16]. Biomarkers that were suggested after trauma included neutrophil C5aR expression [13, 14], neutrophil extracellular traps (NETs) [17], neutrophil CD64 expression [18, 19], neutrophil cell size [20], and neutrophil formyl-methionyl-leucyl-phenylalanine (fMLF)-induced FcγRII expression, of which only the latter was found to be an early marker in multiple trauma cohorts [21, 22]. Neutrophil fMLF-induced FcγRII expression measured immediately after trauma showed high sensitivity (90%) for the prediction of severe sepsis ≥ 5 days post-trauma [21]. This suggests that those patients who are at risk for severe infectious complications can be identified on admission already. However, specificity was rather low (20%) [21], indicating that a large portion of these high-risk patients did not develop septic shock eventually. Possibly, this is because of decisions made in the days after admission. For example, the type of chosen antibiotics and timing of surgery can influence the risk of infections [23,24,25]. Therefore, there is an unmet need for a biomarker to monitor high-risk trauma patients in the early days after admission.

During these initial days, an adequately functioning neutrophil compartment is critical to prevent infectious complications as these cells are vital in the uptake and destruction of microbes [1, 8, 9]. Neutrophil phagocytosis and neutrophil phagosomal acidification are two critical steps in this process [26]. Both can be assessed by flow analysis of neutrophils phagocytosing bioparticles coupled to pH-sensitive and pH-insensitive dyes [27]. Neutrophil subsets, including CD16dim/CD62Lbright cells (banded neutrophils) that were found to have different antimicrobial function [28], can be analyzed in the same assay with the same machine as for determination of neutrophil function. Until now, however, flow analysis was too complex, operator-dependent, time-consuming, and laborious to be applicable in a clinical setting [28, 29]. Recently, a flow cytometer became available that is able to prepare and analyze whole blood fast (< 25 min), highly reproducible, and fully automated [30,31,32]. Hence, we used such an approach to develop a new assay for neutrophil function (phagocytosis and phagosomal acidification) and neutrophil subsets that can be performed as a point-of-care test by any health care worker. The aim of this proof-of-principle study was to investigate whether this assay was suitable for monitoring neutrophil functional capacity in the ICU and identify patients who will develop infectious complications after severe trauma.

Material and methods

Study design

This prospective cohort study analyzed neutrophil functionality within the first 2 weeks after trauma in severely injured trauma patients. Patients were only included after written informed consent of the patient or his/her legal representative, in accordance with the Declaration of Helsinki. All experiments were performed in accordance with the relevant guidelines and regulations. The study was approved by the University Medical Centre Utrecht ethical review committee (protocol no. 13/325). The trial was registered online on the website of the Central Committee on Research Involving Human Subjects before participant enrollment started (NL43279.041.13). The process and storage of data were in accordance with privacy and ethics regulations.

Patients

Severely injured patients ≥ 18 years of age with an expected ICU stay of ≥ 48 h were included between November 2018 and July 2019. Patients were excluded if they recently (< 3 months before hospital admission) used immunosuppressive medication, had an immunosuppressive disorder, or were admitted to ICU because of isolated neurologic injury. Blood was drawn in sodium heparine tubes as soon as possible after trauma (< 12 h), after 3 days, 6 days, 10 days, and 15 days. Control blood samples were provided by anonymous, sex- and age-matched, healthy volunteers. Data concerning patient characteristics, trauma mechanism, injuries, resuscitation, and treatment were obtained from the electronic medical record system. The injury severity score (ISS) [33] based on the abbreviated injury scale 2008 (AIS08) [34] was obtained from the National Trauma Registration database that collects data of all trauma patients admitted to the emergency department [35, 36].

Experimental setup

Fluorescent double-labeling of bioparticles

pHrodo® Green Staphylococcus aureus (S. aureus) BioParticlesTM (Thermo Fisher Scientific, Waltham, MA, USA) were labeled with PromoFluor 520 LSS NHS ester (PF520) (PromoCell, Heidelberg, Germany) following the instructions of the manufacturer. In short, PF520 was dissolved in DMSO at a concentration of 2.5 mg/ml and the bioparticles were suspended in a 0.1-M NaHCO3 pH 9 buffer at room temperature at a concentration of 10 mg/ml (3 × 109 particles/ml). Bioparticles were sonicated to prevent clumping. Then, PF520 was added drop-wise while the bioparticle suspension was vortexed. The suspension was mixed for 1 h in the dark at room temperature, after which the double-labeled bioparticles were washed 3 times. Bioparticles were suspended in a pH 7.4 buffer containing 20 mM HEPES, 132 mM NaCl, 6 mM KCl, 1 mM MgSO4, 1.2 mM KH2PO4, 1.0 mM CaCl2, 5 mM glucose, and 5 mg/ml human serum albumin (Albuman 200 g/l, Sanquin, Amsterdam, the Netherlands).

Flow cytometry analysis

All experiments were performed with whole blood using the fully automated AQUIOS CL® “Load & Go” flow cytometer (Beckman Coulter, Brea, CA, USA) at 30 °C [32]. Firstly, the AQUIOS CL® automatically incubated whole blood with the double-labeled S. aureus bioparticles (end concentration of 10 × 106/ml) and with antibody-fluorochrome conjugates for the neutrophil receptors CD16 (clone 3G8, PE labeled; Beckman Coulter) and CD62L (clone DREG56, ECD labeled; Beckman Coulter). Then, after 10, 20, 40, and 60 min of incubation, the AQUIOS CL® was programmed to aspirate part of the sample, to lyse red blood cells (RBCs), and to perform flow cytometric analysis of the leukocytes. Lysing is performed by the addition of 335 μl of lysing reagent A (Beckman Coulter) followed by 100 μl of lysing reagent B (Beckman Coulter). Lysing reagent A is a cyanide-free lytic reagent that lyses red blood cells, and lysing reagent B slows the reaction caused by reagent A and preserves the white blood cells for measurement in the flow cell. The .LMD files were exported and analyzed using Kaluza Analysis Software v2.1 (Beckman Coulter).

Analysis of neutrophil subsets and functionality

The gating strategy is shown in Supplementary Figures 1 and 2. Granulocytes were identified based on their specific forward/side scatter pattern (Supplementary Figure 1a). Neutrophils were identified by selecting granulocytes with CD16 expression (thereby excluding eosinophils) (Supplementary Figure 1b). Percentages of CD16dim/CD62Lbright neutrophils, CD16bright/CD62Lbright neutrophils, and CD16bright/CD62Ldim neutrophils were analyzed as previously described (Supplementary Figure 2) [37]. The acidification of neutrophil phagolysomes was investigated by analyzing both pHrodo® Green fluorescence and PF520 fluorescence. The fluorescence of pHrodo® Green increases when the pH in the phagolysosome decreases [27, 38], while the fluorescence of PF520 is not sensitive for pH changes. Combined analysis of these fluorochromes allows for assessment of phagocytosis, expressed as percentage of PF520-positive neutrophils, and neutrophil phagosomal acidification, expressed as the ratio pHrodo® Green fluorescence divided by PF520 fluorescence (Supplementary Figure 1c-d). This ratio was measured per PF520-positive neutrophil to correct for the number of phagocytosed bioparticles within the cell. The mean ratio of all neutrophils was used as an indicator of acidification. Additionally, mean fluorescence intensities (MFIs) of PF520 and pHrodo® were calculated to gain insight into changes in MFI over time and how this influences the ratio pHrodo® Green fluorescence divided by PF520 fluorescence.

Statistical analysis

Data were analyzed with IBM SPSS version 23 (IBM Corporation, NY, USA) and GraphPad Prism version 8 (GraphPad, La Jolla, CA, USA). The distribution of continuous variables was assessed with the use of the Shapiro-Wilk test and through visual inspection. Clinical outcomes and demographics were presented as median with interquartile range (IQR) and compared between outcome groups using a Fisher’s exact test or a Mann-Whitney U test, as indicated. Generalized estimating equations (GEE) were used to compare neutrophil subset percentages, neutrophil functionality, PF520 MFI, and pHrodo® MFI over time between patients who later develop an infection and patients who do not, and to correct for within-subject correlation. Outcome data of GEE analysis were presented as the beta coefficient (β) with p value. Additionally, to investigate the differences between these groups for every time point, a Mann-Whitney U test was used because data were not normally distributed. Furthermore, neutrophil phagosomal acidification after 60 min was compared between the 3 neutrophil subsets using a one-way ANOVA with a follow-up comparison of the means using Tukey’s correction for multiple comparisons, since data were normally distributed. Statistical significance was defined as a p value < 0.05.

Results

Baseline characteristics

In total, 15 severely injured patients were included. These patients had a median age of 39.0 (24.0–62.0) and median ISS of 33.0 (22.0–36.0) (Table 1). Mechanisms of injuries were traffic accident (n = 11), fall from height (n = 1), physical abuse (n = 1), and gunshot injuries (n = 2). Six patients developed infectious complications, all between day 4 and day 9 after trauma. Four patients died, of whom 2 died due to severe traumatic brain injuries, 1 due to infectious complications in combination with pre-existing liver disease, and 1 due to acute intestinal ischemia. No statistically significant differences in baseline and outcome characteristics were found between patients who developed infectious complications and patients who did not.

Table 1 Baseline and outcome characteristics
Full size table

Neutrophil subsets

No statistically significant differences were found in CD16dim/CD62Lbright neutrophils (β = 1.070, p = 0.132), CD16bright/CD62Lbright neutrophils (β = − 0.934, p = 0.230), and CD16bright/CD62Ldim (β = −0.263, p = 0.397) neutrophils over time between patients who developed an infection and patients who did not (Fig. 1). Also, no statistically significant differences were found between these groups when comparing the percentages of these subsets per single time point.

Fig. 1
figure1

Neutrophil subsets. Percentage of CD16dim/CD62Lbright cells (a), CD16bright/CD62Lbright cells (b), and CD16bright/CD62Ldim cells (c) of patients who developed an infection (red square) and patients who did not (green circle). Patients who developed an infection were compared to patients without infection using generalized estimating equations. No statistically significant differences were found between these groups. Additionally, groups were compared per time point using Student’s T test with correction for multiple comparisons with the Hom-Sidak method. Again, no statistically significant differences were found between groups. Data are presented as mean with the standard error of the mean

Full size image

Neutrophil functionality

Figure 2 depicts neutrophil phagocytosis and neutrophil phagosomal acidification over time after trauma. Neutrophil phagocytosis did not differ between patients and healthy controls (Fig. 2b, c). Also, no statistically significant differences were found in neutrophil phagocytosis over time between patients who developed infectious complications and patients who did not (Fig. 2a, β = − 0.041, p = 0.928). Neutrophil phagosomal acidification, on the other hand, was significantly different between patients with and without infections (Fig. 2d, β = − 0.029, p < 0.001). Patients who did not develop infections showed increased acidification 6 days (p = 0.029), 10 days (p = 0.025), and 15 days (p = 0.026) after trauma compared to healthy individuals (Fig. 2e). Patients who developed an infection, however, showed increased acidification immediately after trauma (p = 0.006) and after 3 days (p = 0.026) compared to healthy individuals, followed by a marked decrease in acidification to low-normal levels 6, 10, and 15 days after trauma (Fig. 2f). When comparing PF520 MFI and pHrodo MFI between outcome groups (Fig. 3a, b), no significant differences were found in PF520 MFI (β = − 381, p = 0.755), whereas pHrodo MFI significantly differed between outcome groups (β = − 3339, p = 0.004). No correlation was found between baseline characteristics and acidification (Supplementary Table 1).

Fig. 2
figure2

Neutrophil functionality. Neutrophil phagocytosis (a–c) and neutrophil phagosomal acidification (d–f) in patients who developed an infection (red square) and patients who did not develop an infection (green circle) after 60 min of incubation with S. aureus bioparticles. Patients developed these infections between day 4 and day 9. Patients with infections were compared to patients without infections with generalized estimating equations (Fig. 2a, d). Additionally, patients were compared to healthy control values using a Mann-Whitney U test (Fig. 2b, c and Fig. 2e, f). Data are presented as mean with the standard error of the mean. Gray areas represent healthy control values (95% confidence interval). PF520 = PromoFluor 520 LSS. S. Aureus = Staphylococcus aureus. Ns = non-significant. *p < 0.05, **p < 0.01, ***p < 0.001

Full size image
Fig. 3
figure3

PromoFluor and pHrodo fluorescence. Neutrophil PromoFluor (a) and pHrodo (b) fluorescence in patients who developed an infection (red square) and patients who did not develop an infection (green circle) after 60 min of incubation with S. aureus bioparticles. Patients with infections were compared to patients without infections with generalized estimating equations. Data are presented as mean with the standard error of the mean. Gray areas represent healthy control values (95% confidence interval). MFI = mean fluorescence intensity. PF520 = PromoFluor 520 LSS. S. aureus = Staphylococcus aureus. Ns = non-significant. **p < 0.01

Full size image

Discussion

The assay on neutrophil acidification as described in this paper showed clear differences in neutrophil phagosomal activity between patients who developed infectious complications and patients who did not. These differences were indicated by differences in pHrodo fluorescence intensity and became more evident when pHrodo fluorescence intensity was divided by PF520 fluorescence intensity to correct for the number of phagocytosed bioparticles per cell, thereby solely investigating acidification. Neutrophil phagosomal acidification was increased within the first 3 days after trauma in patients who later developed infectious complications. Thereafter, neutrophil phagosomal acidification decreased in these patients to levels in the lower normal range. In marked contrast, in neutrophils from patients who did not develop an infection, phagosomal acidification was within the normal range at first, but increased to above reference values during the second week after trauma.

In the past years, many studies focused on neutrophil phagocytosis, but only a limited number of studies investigated the whole process of neutrophil antibacterial function including intracellular processing of bacteria [28, 29, 39]. The whole process of neutrophil antibacterial function was analyzed by measuring bacterial proliferation over hours to days in the presence of isolated neutrophils in suspension or in tissue-like scaffolds [28, 29, 39]. However, these analyses were laborious, time-consuming, and required experienced personnel. Moreover, these analyses required manual isolation of neutrophils which is known to cause artifacts and reduce reproducibility [40, 41]. Therefore, there has been an unmet need for a fast, reproducible, and clinical applicable point-of-care test without the need for (manual) neutrophil isolation. Here we demonstrate a new assay in which neutrophil function can be measured fully automated and point-of-care within 60 min. Moreover, this assay does not only include neutrophil phagocytosis, but also includes neutrophil acidification, as a measurement of intracellular bacterial processing.

It was remarkable that trauma patients who developed infectious complications initially showed better neutrophil acidification than patients who did not. Since different neutrophil subsets exhibit differences in phagosomal acidification (Supplementary Figure 3), an explanation for this finding could have been the presence of better acidifying neutrophils (CD16dim/CD62Lbright) in the peripheral blood of these patients [37]. However, we found no differences in neutrophil subset percentages between these severely injured patients who developed an infection and patients who did not. Hence, the increased acidification was not simply the result of differences in specific neutrophil subsets in the blood.

Next, the increased acidification could be due to neutrophil priming caused by inflammatory mediators or damage-associated molecular patterns (DAMPs) released by the extensive tissue damage and disrupted protective barriers through which microbes could have entered the body [42]. This hypothesis was supported by the increased acidification within the first 3 days that was most evident in patients who later developed an infection. This suggested that these patients exhibited a more pronounced inflammatory response. Since neutrophil lifespan is estimated to be 4–5 days and it takes 6–7 days to mobilize new neutrophils into the blood [43, 44], early mobilization (1–2 days after trauma) of too many well-functioning neutrophils might have led to a relative shortage of such neutrophils after 6 days. This is supported by the decrease in phagosomal acidification observed in patients at the time of infection. Moreover, it is possible that the infections caused a migration of well-functioning neutrophils into tissues leading to a further decrease of well-functioning neutrophils in the blood, a phenomenon previously described as a refractory immune state [45].

Surprisingly, ISS [1, 46] did not significantly differ between patients who developed infections and patients who did not, whereas it has recently been found that both correlated with the risk of infectious complications. Most likely, this was because we only included “high-risk” patients by selecting the most severely injured patients for this study. It should be taken into account that the study population was small. Although the study population was sufficient for the aim of this proof-of-principle study, it is possible that with a larger study population, ISS and resuscitation would have significantly differed between patients with and without infection. However, despite low patient numbers, we still found clear differences in neutrophil phagosomal acidification already before patients developed their infection. This suggests that the neutrophil phagosomal acidification assay is a valuable test for predicting and monitoring high-risk patients for infectious complications after trauma.

For future optimization of this assay, several aspects can be considered. First, although granulocytes and lymphocytes can be easily distinguished on their specific forward/side scatter pattern (Supplementary Figure 1a), it is not always possible to distinguish monocytes. Therefore, if monocyte analysis is warranted, a monocyte-specific marker should be used. Secondly, the positive and negative populations measured by the PF520 signal somewhat overlap. Therefore, it might be valuable to investigate other brighter fluorochromes. An additional advantage of this could be that a brighter fluorochrome might enable better quantification of the number of phagocytosed bioparticles per cell, which could be of interest when investigating the phagocyte capacity of specific cell types. Thirdly, it should be taken into account that temperature changes influence the outcomes of this assay. Although acidification remains relatively stable, phagocytosis clearly increases as the temperature increases (Supplementary Figure 4). To ensure assay stability, it is therefore recommended to perform this analysis in a room with a constant temperature. Lastly, our gating strategy was based on visual estimation by 2 independent researchers. For future studies, it is worthwhile to investigate a more standardized gating strategy.

Conclusion

Neutrophil function in terms of phagocytosis and acidification can now be measured quickly and fully automated in the ICU as point-of-care test. After severe trauma, neutrophil phagosomal acidification differs between patients who develop infectious complications and patients who do not. Hence, this new assay might be an asset to monitor the inflammatory status of trauma patients in the ICU and identify patients who develop infectious complications.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

AIS:

Abbreviated injury scale

CRP:

C-reactive protein

DAMPs:

Damage-associated molecular patterns

fMLF:

Formyl-methionyl-leucyl-phenylalanine

GEE:

Generalized estimating equations

ICU:

Intensive care unit

IQR:

Interquartile range

ISS:

Injury severity score

MFI:

Mean fluorescence intensity

Ns:

Non-significant

PF520:

PromoFluor 520 LSS

RBC:

Red blood cells

S. aureus :

Staphylococcus aureus

References

  1. 1.

    Hietbrink F, Koenderman L, Rijkers G, Leenen L (2006) Trauma: the role of the innate immune system. World J Emerg Surg 1:15. https://doi.org/10.1186/1749-7922-1-15

  2. 2.

    Keel M, Trentz O (2005) Pathophysiology of polytrauma. Injury 36:691–709. https://doi.org/S0020-1383(04)00552-2 [pii]

  3. 3.

    Cole E, Davenport R, Willett K et al (2014) The burden of infection in severely injured trauma patients and the relationship with admission shock severity. 76:730–735. https://doi.org/10.1097/TA.0b013e31829fdbd7

  4. 4.

    Van Wessem KJP, Leenen LPH, Van Wessem KJP (2017) Reduction in mortality rates of postinjury multiple organ dysfunction syndrome: a shifting paradigm? A prospective population based cohort study. Shock 49:33–38. https://doi.org/10.1097/SHK.0000000000000938

  5. 5.

    Wafaisade A, Lefering R, Bouillon B et al (2011) Epidemiology and risk factors of sepsis after multiple trauma: an analysis of 29,829 patients from the Trauma Registry of the German Society for Trauma Surgery. Crit Care Med 39:621–628. https://doi.org/10.1097/CCM.0b013e318206d3df

  6. 6.

    Chung S, Choi D, Cho J et al (2018) Timing and associated factors for sepsis-3 in severe trauma patients: a 3-year single trauma center experience. Acute Crit Care 33:130–134. https://doi.org/10.4266/acc.2018.00122

  7. 7.

    Jin H, Liu Z, Xiao Y et al (2014) Prediction of sepsis in trauma patients. Burn Trauma 2:106–113. https://doi.org/10.4103/2321-3868.135479

  8. 8.

    Kubes P (2018) The enigmatic neutrophil: what we do not know. Cell Tissue Res 371:399–406

  9. 9.

    Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159–175. https://doi.org/10.1038/nri3399

  10. 10.

    Hietbrink F, Koenderman L, Althuizen M et al (2013) Kinetics of the innate immune response after trauma. Shock 40:21–27. https://doi.org/10.1097/SHK.0b013e318295a40a

  11. 11.

    Groeneveld KM, Heeres M, Leenen LPH et al (2012) Immunophenotyping of posttraumatic neutrophils on a routine haematology analyser. Mediators Inflamm 2012:509513. https://doi.org/10.1155/2012/509513

  12. 12.

    Visser T, Hietbrink F, Groeneveld KM et al (2011) Isolated blunt chest injury leads to transient activation of circulating neutrophils. Eur J Trauma Emerg Surg 37:177–184. https://doi.org/10.1007/s00068-010-0041-x

  13. 13.

    Amara U, Kalbitz M, Perl M et al (2010) Early expression changes of complement regulatory proteins and c5a receptor (cd88) on leukocytes after multiple injury in humans. Shock 33:568–575. https://doi.org/10.1097/SHK.0b013e3181c799d4

  14. 14.

    Morris AC, Brittan M, Wilkinson TS et al (2011) C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood 117:5178–5189. https://doi.org/10.1182/blood-2010-08-304667.The

  15. 15.

    Mortaz E, Zadian SS, Shahir M et al (2019) Does neutrophil phenotype predict the survival of trauma patients? Front Immunol 10:1–14. https://doi.org/10.3389/fimmu.2019.02122

  16. 16.

    Monneret G, Venet F (2016) Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy. Cytom Part B - Clin Cytom 90:376–386. https://doi.org/10.1002/cyto.b.21270

  17. 17.

    Meng W, Paunel-Görgülü A, Flohé S et al (2012) Deoxyribonuclease is a potential counter regulator of aberrant neutrophil extracellular traps formation after major trauma. Mediators Inflamm 2012:149560. https://doi.org/10.1155/2012/149560

  18. 18.

    Cid J, Aguinaco R, Sánchez R et al (2010) Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis. J Infect 60:313–319. https://doi.org/10.1016/j.jinf.2010.02.013

  19. 19.

    Djordjevic D, Pejovic J, Surbatovic M et al (2015) Prognostic value and daily trend of interleukin-6, neutrophil CD64 expression, C-reactive protein and lipopolysaccharide-binding protein in critically ill patients: reliable predictors of outcome or not? J Med Biochem 34:431–439. https://doi.org/10.1515/jomb-2015-0002

  20. 20.

    Hesselink L, Heeres M, Paraschiakos F et al (2019) A rise in neutrophil cell size precedes organ dysfunction after trauma. Shock 51:439–446. https://doi.org/10.1097/SHK.0000000000001200

  21. 21.

    Groeneveld KM, Koenderman L, Warren BL et al (2017) Early decreased neutrophil responsiveness is related to late onset sepsis in multitrauma patients: an international cohort study. PLoS One 12:e0180145

  22. 22.

    Hietbrink F, Koenderman L, Althuizen M, Leenen LPH (2009) Modulation of the innate immune response after trauma visualised by a change in functional PMN phenotype. Injury 40:851–855. https://doi.org/10.1016/j.injury.2008.11.002

  23. 23.

    Pape HC, Hildebrand F, Pertschy S et al (2002) Changes in the management of femoral shaft fractures in polytrauma patients: from early total care to damage control orthopedic surgery. J Trauma 53:452. https://doi.org/10.1097/01.TA.0000025660.37314.0F

  24. 24.

    Bongers S, Hellebrekers P, Leenen L et al (2019) Intracellular penetration and effects of antibiotics on Staphylococcus aureus inside human neutrophils: a comprehensive review. Antibiotics 8:1–22. https://doi.org/10.3390/antibiotics8020054

  25. 25.

    Lane JCE, Mabvuure NT, Hindocha S, Khan W (2012) Current concepts of prophylactic antibiotics in trauma: a review. Open Orthop J 6:511–517

  26. 26.

    Eddie W, Sokolovska A, Charriere G et al (2010) Phagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus. J Immunol 184:7071–7081. https://doi.org/10.1038/jid.2014.371

  27. 27.

    Simons ER (2010) Measurement of phagocytosis and of the phagosomal environment in polymorphonuclear phagocytes by flow cytometry. Curr Protoc Cytom Jan:Chapter 9:Unit9.31. https://doi.org/10.1002/0471142956.cy0931s51

  28. 28.

    Leliefeld PHC, Pillay J, Vrisekoop N et al (2018) Differential antibacterial control by neutrophil subsets. Blood Adv 2:1344–1355. https://doi.org/10.1182/bloodadvances.2017015578

  29. 29.

    van Grinsven E, Leliefeld PHC, Pillay J et al (2018) A comprehensive three-dimensional assay to assess neutrophil defense against bacteria. J Immunol Methods 462:83–90. https://doi.org/10.1016/j.jim.2018.09.001

  30. 30.

    Degandt S, Peeters B, Jughmans S et al (2018) Analytical performance of an automated volumetric flow cytometer for quantitation of T, B and natural killer lymphocytes. Clin Chem Lab Med 56:1277–1288. https://doi.org/10.1515/cclm-2017-0638

  31. 31.

    Coetzee LM, Glencross DK (2017) Performance verification of the new fully automated Aquios flow cytometer PanLeucogate (PLG) platform for CD4-T-lymphocyte enumeration in South Africa. PLoS One 12:1–17. https://doi.org/10.1371/journal.pone.0187456

  32. 32.

    Spijkerman R, Hesselink L, Hellebrekers P et al (2019) Automated flow cytometry enables high performance point-of-care analysis of leukocyte phenotypes. J Immunol Methods 474:112646. https://doi.org/10.1016/j.jim.2019.112646

  33. 33.

    Baker SP, O’Neill B, Haddon W, Long WB (1974) The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14:187–196 https://doi.org/4814394

  34. 34.

    Gennarelli TA, Wodzin E (2008) Abbreviated injury scale 2005: update 2008. Barrington, Ill. : Association for the advancement of automative medicine

  35. 35.

    Gunning AC, Lansink KWW, Van Wessem KJP et al (2015) Demographic patterns and outcomes of patients in level I trauma centers in three international trauma systems. World J Surg 39:2677–2684. https://doi.org/10.1007/s00268-015-3162-x

  36. 36.

    Lansink KWW, Gunning AC, Spijkers ATE, Leenen LPH (2013) Evaluation of trauma care in a mature level I trauma center in The Netherlands: outcomes in a Dutch mature level I trauma. World J Surg 37:2353–2359. https://doi.org/10.1007/s00268-013-2103-9

  37. 37.

    Pillay J, Kamp VM, Van Hoffen E et al (2012) A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 122:327–336. https://doi.org/10.1172/JCI57990DS1

  38. 38.

    Lich KE, Neaga A, Xiao YQ et al (2011) Development and validation of a flow cytometric method to evaluate phagocytosis of pHrodoTM BioParticles® by granulocytes in multiple species. J Immunol Methods 390:9–17. https://doi.org/10.1016/j.jim.2011.06.027

  39. 39.

    Li Y, Karlin A, Loike JD, Silverstein SC (2004) Determination of the critical concentration of neutrophils required to block bacterial growth in tissues. J Exp Med 200:613–622. https://doi.org/10.1084/jem.20040725

  40. 40.

    Alvarez-Larrán A, Toll T, Rives S, Estella J (2005) Assessment of neutrophil activation in whole blood by flow cytometry. Clin Lab Haematol 27:41–46. https://doi.org/10.1111/j.1365-2257.2004.00661.x

  41. 41.

    Glasser L, Fiederlein R (1990) The effect of various cell separation procedures on assays of neutrophil function. A critical appraisal. Am J Clin Pathol 93:662–669

  42. 42.

    Miralda I, Uriarte SM, Mcleish KR (2017) Multiple phenotypic changes define neutrophil priming. 7:1–13. https://doi.org/10.3389/fcimb.2017.00217

  43. 43.

    Tak T, Wijten P, Heeres M et al (2017) Human CD62L dim neutrophils identified as a separate subset by proteome profiling and in vivo pulse-chase labeling. Blood 129:3476–3486. https://doi.org/10.1182/blood-2016-07-727669.The

  44. 44.

    Pillay J, Den Braber I, Vrisekoop N et al (2010) In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 116:625–627. https://doi.org/10.1182/blood-2010-01-259028

  45. 45.

    Hesselink L, Spijkerman R, Van Wessem KJP et al (2019) Neutrophil heterogeneity and its role in infectious complications after severe trauma. World J Emerg Surg 14:24. https://doi.org/10.1186/s13017-019-0244-3

  46. 46.

    Kaufman EJ, Earl-royal E, Barie PS, Holena DN (2017) Failure to rescue after infectious complications. 18:89–98. https://doi.org/10.1089/sur.2016.112

Download references

Acknowledgements

The authors want to thank Paul van Hoof, Roelof-Jan van der Lei, Geert Weijers, Andreas Boehmler, and Markus Kaymer from the Beckman Coulter team for technical support during the study.

Funding

No funding was received for this study.

Author information

Affiliations

  1. Department of Trauma Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, the Netherlands
    • Lillian Hesselink
    • , Roy Spijkerman
    • , Emma de Fraiture
    • , Suzanne Bongers
    • , Karlijn J. P. Van Wessem
    • , Luke P. H. Leenen
    •  & Falco Hietbrink
  2. Department of Respiratory Medicine, Wilhelmina Children’s Hospital, Lundlaan 6, 3584, EA, Utrecht, the Netherlands
    • Leo Koenderman
  3. Center for Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, the Netherlands
    • Lillian Hesselink
    • , Roy Spijkerman
    • , Emma de Fraiture
    • , Suzanne Bongers
    • , Nienke Vrisekoop
    •  & Leo Koenderman
  4. Department of Trauma Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands
    • Lillian Hesselink
Authors
  1. Lillian Hesselink
    View author publications
    You can also search for this author in
  2. Roy Spijkerman
    View author publications
    You can also search for this author in
  3. Emma de Fraiture
    View author publications
    You can also search for this author in
  4. Suzanne Bongers
    View author publications
    You can also search for this author in
  5. Karlijn J. P. Van Wessem
    View author publications
    You can also search for this author in
  6. Nienke Vrisekoop
    View author publications
    You can also search for this author in
  7. Leo Koenderman
    View author publications
    You can also search for this author in
  8. Luke P. H. Leenen
    View author publications
    You can also search for this author in
  9. Falco Hietbrink
    View author publications
    You can also search for this author in

Contributions

All authors contributed to the conceptualization and study design. FH, LPHL, LK, and KJPW set up the study. FH, RS, SB, and LH contributed to patient enrollment. RS, SB, EF, and LH performed the experiments. RS and LH performed the analyses. All authors contributed to the interpretation of the data. RS, SB, EF, and LH contributed to the visualization of the data. LH wrote the initial draft. All other authors made significant revisions to the manuscript. The authors approved the final manuscript.

Corresponding author

Correspondence to Lillian Hesselink.

Ethics declarations

Ethics approval and consent to participate

Patients were only included after written informed consent of the patient or his/her legal representative. The study was approved by the University Medical Centre Utrecht ethical review committee (protocol no. 13/325).

Consent for publication

All patients gave written informed consent for publication.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1: Supplementary Figure 1. Gating strategy for the determination of neutrophil phagocytosis and acidification. Granulocytes and lymphocytes can be distinguished on the forward scatter (FS)/side scatter (SS) (a). Neutrophils were identified by selecting granulocytes with CD16 expression (thereby excluding eosinophils) (b). Combined analysis of pHrodo® Green fluorescence and PF520 fluorescence allows for assessment of phagocytosis, expressed as a percentage of PF520-positive neutrophils (c), and neutrophil phagosomal acidification, expressed as the ratio pHrodo® Green fluorescence divided by PF520 fluorescence (d). PF520 = PromoFluor 520 LSS.

Additional file 2: Supplementary Figure 2. Gating strategy for distinguishing neutrophil subsets. The gating of the neutrophil subsets CD16dim/CD62Lbright, CD16bright/CD62Lbright and CD16bright/ CD62Ldim is shown.

Additional file 3: Supplementary Table 1. Correlation between baseline characteristics and acidification. The relation between acidification and baseline variables was analyzed. For continuous variables (age, ISS, RBCs, FFPs and PLTs), correlation was analyzed using the Spearman’s rho test because data were not normally distributed. Correlation coefficient and p-value are reported. No statistically significant correlations were found. The relation between acidification and gender was analyzed using a Mann-Whitney U test, because data were not normally distributed. U-value and p-value are reported. No statistically significant differences were found.

Additional file 4: Supplementary Figure 3. Neutrophil phagosomal acidification per neutrophil subset. Neutrophil phagosomal acidification of CD16dim/CD62Lbright cells (), CD16bright/CD62Lbright cells () and CD16bright/ CD62Ldim cells () in all patients after 10, 20, 40 and 60 minutes of incubation with S. Aureus bioparticles. Neutrophil phagosomal acidification after 60 minutes was compared between subsets using a one-way ANOVA. Significant differences were found between subsets (p < 0.001). A follow-up comparison of the means was performed with a Tukey’s correction for multiple comparisons. CD16dim/CD62Lbright neutrophils were found to acidify significantly better than CD16bright/CD62Lbright neutrophils (p = 0.016) and then CD16bright/CD62Lbright neutrophils (p < 0.001). MFI = median fluorescence intensity. PF520 = PromoFluor 520 LSS. S. Aureus = Staphylococcus Aureus. Data are presented as mean with standard error of the mean. *P<0.05, **P<0.01, ***P<0.001.

Additional file 5: Supplementary Figure 4. Effect of temperature changes on neutrophil function. Neutrophil phagocytosis (a) and neutrophil phagosomal acidification (b) in five healthy controls at different temperatures. Blood from 5 healthy controls was analyzed after incubation for 60 minutes with double-labeled bioparticles on ice, in a water bath of 25°C and in a water bath of 37°C. Then, red blood cells were lysed using lysing reagent A and lysing reagent B from the AQUIOS CL® “Load & Go” flow cytometer and leukocyte analysis was performed using the BD FACSCanto™ II (BD Biosciences). Temperature conditions were compared using a Friedman test and a Mann-Whitney U Test with a Dunn's correction for multiple comparisons. Neutrophil phagocytosis and neutrophil acidification significantly differed at different temperatures (p = 0.0008 and p = 0.0394, respectively). Neutrophil phagocytosis increased as the temperature increased, and significant differences were found between samples that were kept on ice and samples that were kept in 37°C (p = 0.005). Such a temperature dependent trend was not observed for neutrophil acidification. However, significant differences were found between 25°C and 37°C (p = 0.034).

Additional file 6: Supplementary Figure 5. Effect of CD16/CD62L-antibodies on neutrophil function. Neutrophil phagocytosis (a) and neutrophil phagosomal acidification (b) in five healthy controls after 60 minutes of incubation with S. Aureus bioparticles. Per patient, this analysis was performed three times in different conditions: 1) with 6 μL Hepes buffer, 2) with 6 μL CD16-BV785 and 3) with 6 μL CD62L-BV650. The Hepes buffer and antibody-fluorochrome combinations were added to the wells plate prior to initiation of the functional analyses to prevent a time delay between the different analyses. The Hepes buffer consisted of 20 mM Hepes, 132 mM NaCl, 6 mM KCl, 1.2 mM KH2PO4 and 1 mM MgSO4, supplemented with 5 mM glucose, 1 mM CaCl2, and 0.5% (w/v) human serum albumin. The CD16/CD62L-antibody-fluorochrome combinations were chosen because the fluorochromes are not excited by the 488 laser of the AQUIOS CL® “Load & Go” flow cytometer. A Friedman test was used to compare the three different conditions. No significant differences in neutrophil phagocytosis and neutrophil phagosomal acidification were found after the addition of CD16 and CD62L antibodies. Data are presented as individual values with mean (black line). MFI = median fluorescence intensity. PF520 = PromoFluor 520 LSS. S. Aureus = Staphylococcus Aureus. Ns = non-significant.

Additional file 7: Supplementary Figure 6. Bioparticles were internalized in neutrophils. ImageStream analysis showed that the bioparticles (green) were internalized in the neutrophil (staining of CD16 on cell membrane in blue). The experiment was performed using the Amnis® ImageStream®XMk II and data were analyzed using Exploration Software (IDEAS, Luminex, Austin, USA).

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hesselink, L., Spijkerman, R., de Fraiture, E. et al. New automated analysis to monitor neutrophil function point-of-care in the intensive care unit after trauma. ICMx 8, 12 (2020). https://doi.org/10.1186/s40635-020-0299-1

Download citation

Keywords

  • Intensive care
  • Trauma
  • Infections
  • Neutrophils
  • Point-of-care
  • Bedside
  • Monitoring